Overlap of spike and ripple propagation onset predicts surgical outcome in epilepsy
SRO is a specific and precise biomarker of the epileptogenic zone whose removal predicts outcome. SRO is present in most patients with drug-resistant epilepsy. Such a biomarker may reduce prolonged intracranial monitoring and improve outcome.
Authors
- Christos Papadelis (ORCID: https://orcid.org/0000-0001-6125-9217)
- Michael Scott Perry (ORCID: https://orcid.org/0000-0002-1825-846X)
- Lorenzo Fabbri
- Scellig S. D. Stone (ORCID: https://orcid.org/0000-0002-4546-6790)
- Margherita A. G. Matarrese (ORCID: https://orcid.org/0000-0001-9833-9886)
- Saeed Jahromi (ORCID: https://orcid.org/0000-0002-1850-5299)
- Eleonora Tamilia (ORCID: https://orcid.org/0000-0002-1235-3052)
- Phillip L. Pearl (ORCID: https://orcid.org/0000-0002-6373-1068)
- Joseph R. Madsen
- Jeffrey Bolton (ORCID: https://orcid.org/0000-0003-2949-8722)
Institutions
- Boston Children's Hospital (US)
- Texas Christian University (US)
- Harvard University (US)
- Università Campus Bio-Medico (IT)
- The University of Texas at Arlington (US)
- Cook Children's Health Care System (US)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1002/acn3.52156
- Citations
- 10
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.86
Funders
- Children's Health Foundation
- National Institute of Neurological Disorders and Stroke